Skip to main content
SM

Shawn Menefee

🏥 Kaiser Permanente San Diego, San Diego, CA

Biography​

Shawn A. Menefee directs the Division of Female Pelvic Medicine and Reconstructive Surgery at Kaiser Permanente San Diego Medical Center.1 He earned his medical degree at the University of Tennessee and completed an obstetrics and gynecology residency at Naval Medical Center Portsmouth.1 He completed a urogynecology fellowship at Louisiana State University Medical Center in New Orleans.2 He has served as co-director of the UC San Diego and Kaiser Permanente fellowship and was president of the American Urogynecologic Society in 2019–2020.34

Contributions​

His cited work studies surgical approaches and reoperation after pelvic organ prolapse repair, including the ASPIRe trial and anterior vaginal wall repair. Other cited trials compare treatments for urinary incontinence, including sacral neuromodulation, onabotulinumtoxinA, and midurethral slings.56789

Cited on WARWIKI

9 publications with Shawn Menefee as a listed author are cited on WARWIKI, ordered by the number of pages that cite them. Papers whose author list is shortened to "et al." before this name are not included.

  1. Menefee SA, Richter HE, Myers D, et al. Apical suspension repair for vaginal vault prolapse: a randomized clinical trial. JAMA Surg. 2024;159:845–855. doi
    Cited on: Apical Prolapse · POP Overview · Michigan Four-Wall Sacrospinous Ligament Suspension
  2. Amundsen CL, Richter HE, Menefee SA, et al. "OnabotulinumtoxinA vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial." JAMA. 2016;316(13):1366–1374. doi
    Cited on: Botulinum Toxin (Neuromodulation Adjunct) · Medtronic InterStim — Sacral Neuromodulation · Intradetrusor OnabotulinumtoxinA
  3. Harvie HS, Menefee SA, Richter HE, et al. "Midurethral Sling vs OnabotulinumtoxinA in Females With Urinary Incontinence: The MUSA Randomized Clinical Trial." JAMA. 2025;333(21):1887–1896. doi
    Cited on: Mixed Urinary Incontinence · Female Slings & Suspensions · Intradetrusor OnabotulinumtoxinA
  4. Tan-Kim J, Shah NM, Do D, Menefee SA. "Efficacy of vaginal estrogen for recurrent urinary tract infection prevention in hypoestrogenic women." Am J Obstet Gynecol. 2023;229(2):143.e1–143.e9. doi
    Cited on: Vaginal and Topical Estrogen · Non-Antibiotic UTI Prevention · Recurrent UTI in Women
  5. Erekson E, Menefee SA, Whitworth R, et al. Outcomes by frailty and mobility in older patients undergoing major urogynecologic surgery: a planned supplementary study of the ASPIRe trial. Am J Obstet Gynecol. 2026;234:689–729. doi
    Cited on: Frailty · Geriatric Urogynecology & Reconstructive Urology
  6. Shah NM, Berger AA, Zhuang Z, Tan-Kim J, Menefee SA. "Long-Term Reoperation Risk After Apical Prolapse Repair in Female Pelvic Reconstructive Surgery." American Journal of Obstetrics and Gynecology. 2022;227(2):306.e1-306.e16. doi
    Cited on: Uterosacral Ligament Suspension (USLS) · Colpocleisis (Le Fort and Total)
  7. Berger AA, Tan-Kim J, Menefee SA. "Anchor vs suture for the attachment of vaginal mesh in a robotic-assisted sacrocolpopexy: a randomized clinical trial." Am J Obstet Gynecol. 2020;223(2):258.e1–258.e8. doi
    Cited on: Sacrocolpopexy Tacker
  8. Berger AA, Tan-Kim J, Menefee SA. "Long-Term Risk of Reoperation After Synthetic Mesh Midurethral Sling Surgery for Stress Urinary Incontinence." Obstet Gynecol. 2019;134(5):1047-1055. doi
    Cited on: Female Slings & Suspensions
  9. Menefee SA, Dyer KY, Lukacz ES, et al. "Colporrhaphy Compared With Mesh or Graft-Reinforced Vaginal Paravaginal Repair for Anterior Vaginal Wall Prolapse: A Randomized Controlled Trial." Obstet Gynecol. 2011;118(6):1337-1344. doi
    Cited on: Paravaginal Repair

Footnotes​

  1. Shawn A. Menefee, MD. Kaiser Permanente Department of Research & Evaluation. Accessed October 2026. ↩ ↩2

  2. 28th%20Annual%20Research%20Day%20Booklet%202016.pdf. Accessed October 2026. ↩

  3. Urogynecology & Reconstructive Pelvic Surgery. Accessed October 2026. ↩

  4. Past Presidents. AUGS. Accessed October 2026. ↩

  5. Menefee SA, Richter HE, Myers D, et al. Apical suspension repair for vaginal vault prolapse: a randomized clinical trial. JAMA Surg. 2024;159:845–855. doi:10.1001/jamasurg.2024.1206 ↩

  6. Amundsen CL, Richter HE, Menefee SA, et al. "OnabotulinumtoxinA vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial." JAMA. 2016;316(13):1366–1374. doi:10.1001/jama.2016.14617 ↩

  7. Harvie HS, Menefee SA, Richter HE, et al. "Midurethral Sling vs OnabotulinumtoxinA in Females With Urinary Incontinence: The MUSA Randomized Clinical Trial." JAMA. 2025;333(21):1887–1896. doi:10.1001/jama.2025.4682 ↩

  8. Erekson E, Menefee SA, Whitworth R, et al. Outcomes by frailty and mobility in older patients undergoing major urogynecologic surgery: a planned supplementary study of the ASPIRe trial. Am J Obstet Gynecol. 2026;234:689–729. doi:10.1016/j.ajog.2025.11.002 ↩

  9. Shah NM, Berger AA, Zhuang Z, Tan-Kim J, Menefee SA. "Long-Term Reoperation Risk After Apical Prolapse Repair in Female Pelvic Reconstructive Surgery." American Journal of Obstetrics and Gynecology. 2022;227(2):306.e1-306.e16. doi:10.1016/j.ajog.2022.05.046 ↩